Clinical Trial Update: Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating glutaminase inhibition with chemoradiation for advanced cervical cancer; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Glutaminase inhibitor

Snippet

Sponsor: Washington University School of Medicine | Conditions: Advanced Cervical Carcinoma, Cervical Cancer | Phase 2 | Status: NOT_YET_RECRUITING